Ping An to launch new AI-driven healthcare joint ventures in China

Ping An, China's largest insurer by market size, has signed agreements with Shionogi & Co to launch joint ventures in Shanghai and Hong Kong, with a total investment of $466.4 million, to develop a data-driven drug discovery and development platform.

The rest of this article is locked for subscribers only. Please login to continue reading.

If you don't have a login, you will need to purchase a subscription to gain access to this article, including all our online content. Please use this link and follow the steps.

To request a FREE 2-week trial subscription, use the same link but select the 'trial' option in the dropdown box. NOTE - this can take up to 48hrs to be approved.

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Elliot Field at efield@newtonmedia.co.uk or Adrian Tapping at atapping@newtonmedia.co.uk

Ping An, Shionogi & Co, Partnership, Insurance, Reinsurance, Artificial Intelligence, John Keller, China

More on this story

China's Ping An launches strategic partnership with specialty MGA Fusion
08-07-2021

Swiss Re to lead AI-driven smart claims solutions in Europe
05-08-2020

China's Ping An expands financial services footprint
27-04-2020

Standard Club partners with China's Ping An to underwrite P&I risks
09-11-2018

Ping An to launch new AI-driven healthcare joint ventures in China

More on this story

Other related

More on this story

Sign up for the newsletter